USPTO serial 79394750
BREASTEST
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 18, 2025
- Examiner
- OH, HYUN-JUNG
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BREASTEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicholas D. Myers
Nicholas D. Myers THE MYERS LAW GROUP4695 MacArthur Court, Suite 200Newport Beach, CA 92660United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for testing blood for medical purposes; diagnostic preparations for clinical, medical or veterinary laboratory use; diagnostic preparations for medical purposes; diagnostic products in the nature of medical diagnostic biomarkers for medical purposes; diagnostic substances for medical use; diagnostic testing materials in the nature of diagnostic test patch for application to the skin for determining allergies for medical use; diagnostic agents for pharmaceutical use; diagnostic reagents for medical purposes; preparations for medical diagnostic use; reagents for blood grouping for medical purposes; blood testing apparatus including test erythrocytes for blood diagnostic purposes; medical adhesive tapes; medical dressings; medical or veterinary chemical products in the nature of chemical reagents for diagnostic tests for medical use; medical or veterinary chemical products in the nature of chemical reagents for use in biological preparations for medical purposes; medical or veterinary chemical products in the nature of chemical reagents for use with biotechnology for medical purposes; medical or veterinary chemical preparations in the nature of chemical reagents for the vaccines and antibodies chemical products in the nature of chemical reagents and antibody reagents for the detection of antigens in cells and tissue for medical and veterinary purposes; medical or veterinary chemical preparations for therapeutic , sanitary pharmaceutical purposes for modulating or modifying lipids to improve disease outcomes for conditions including, dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical plasters; medical preparations for the treatment of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical wound dressings | ACTIVE | — |
| 010 | Diagnostic apparatus for carrying out diagnostic tests for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells used in medical laboratories for medical purposes; diagnostic apparatus for diagnostic and medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells; diagnostic apparatus for medical diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and apparatus for blood analysis; blood testing apparatus for blood tests; apparatus for testing blood; medical apparatus for use in blood analysis; medical apparatus for the treatment of cancer; blood cell analyzing apparatus for medical use; blood component separation apparatus for medical use; blood sampling apparatus for medical use; blood testing apparatus; blood testing equipment, namely, hematology analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and electromagnetic medical diagnostic imaging apparatus for medical use; immunochemical medical diagnostic testing apparatus for use in detecting and measuring antibody levels immunoassay procedures; immunochemical medical diagnostic testing instruments for use in detecting and measuring antibody levels immunoassay procedure; electromedical diagnostic instruments, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; gamma instruments for measuring human cell attenuation for medical use, namely, gamma cameras for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and medical apparatus for diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells and medical diagnostic apparatus for use in testing blood in medical laboratories; medical apparatus for medical diagnostic testing of biological samples; medical diagnostic apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and medical diagnostic instruments for the analysis of body fluids; medical diagnostic testing apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and testing apparatus for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; testing instruments for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; tools for medical diagnostics, namely, tube for collection of blood samples, hematology analyzers, metabolite analyzers, nucleic acid analyzers for medical diagnostics uses | ACTIVE | — |
| 044 | Medical analysis of tissues for the medical treatment of persons; blood testing services being medical analysis services for diagnostic and treatment purposes by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the diagnosis and treatment of persons; medical analysis services relating to the treatment of patients; medical diagnostic testing, monitoring and reporting services; surgical diagnostic services relating to the treatment of patients for medical purposes; health screening services in the field of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical screening; medical services; medical monitoring and reporting services of patients; remote monitoring of medical data for medical diagnosis and treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BCal Diagnostics Limited
- Other trademarks owned by BCal Diagnostics Limited
- Other trademarks owned by BCal Diagnostics Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named BREASTEST
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 2, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 2, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 19, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 2, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 2, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 31, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 31, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 19, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 19, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 19, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 23, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 20, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 20, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 20, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 20, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 20, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 1, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 10, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 10, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 30, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 10, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |